The Critical Gap in Pharma Omnichannel Marketing

The Critical Gap in Pharma Omnichannel Marketing
ACTO

The role of a field rep has evolved significantly since it was created in the 1960s. Today reps face constant challenges around the speed of innovation, market instability and intense competition. Yet, face-to-face interaction remains the most preferred channel by HCPs. What more can you do to ensure that field reps are providing a positive brand experience to the HCP?

Explore key findings and gain expert perspectives on:

  • Benefits of omnichannel marketing
  • Vital role of F2F interactions as a channel
  • Improving performance and reducing risk

Download the eBook: The Critical Gap in Pharma Omnichannel Marketing

More from Partnered Content

Sponsored by:

Oncology R&D trends at a glance

Access key stats from biotechs on the latest trends impacting oncology R&D, including therapeutic pipelines and clinical trial challenges, AI/ML, and a future outlook on innovation.

Sponsored by:

Infographic: Advancing Drug Development in Oncology

Gain exclusive insights into the biggest challenges biotechs face in oncology and uncover the latest opportunities to accelerate drug development.

Sponsored by:

Japan’s Strengths As A Clinical Study Location And Why Selecting The Right Partner Is Crucial

Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.

Sponsored by:

Roundtable Report: Keeping Pace with CGT Innovation

CGTs are among the fastest-growing areas in therapeutics - explore the key strategies driving long-term commercial success across the entire product lifecycle.

More from Scrip

Sponsored by:

Making medicines more affordable to the NHS

Delve into the challenges facing the NHS, from rising medicine costs to supply shortages, and how generics and branded generics can provide solutions for a more sustainable healthcare system

Sponsored by:

Oncology R&D trends at a glance

Access key stats from biotechs on the latest trends impacting oncology R&D, including therapeutic pipelines and clinical trial challenges, AI/ML, and a future outlook on innovation.

Sponsored by:

Infographic: Advancing Drug Development in Oncology

Gain exclusive insights into the biggest challenges biotechs face in oncology and uncover the latest opportunities to accelerate drug development.

Sponsored by:

Japan’s Strengths As A Clinical Study Location And Why Selecting The Right Partner Is Crucial

Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.